MOC-31 exhibits superior reactivity compared with Ber-EP4 in invasive lobular and ductal carcinoma of the breast: A tissue microarray study

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 3, 2009, Pages 202-206

  Pai, Reetesh K ^a   West, Robert B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ber EP4; Breast; Carcinoma; MOC 31; TACSTD1

Indexed keywords

ANTIBODY; BER EP4 ANTIBODY; MOC 31 ANTIBODY; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; TACSTD1 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GYNECOLOGIC CANCER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRADUCTAL CARCINOMA; KIDNEY CARCINOMA; LIVER CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; STOMACH CARCINOMA; TISSUE MICROARRAY; BREAST TUMOR; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; IMMUNOLOGY; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY;

ANTIBODIES; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL ADHESION MOLECULES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 66549125219     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31818c0f42     Document Type: Article

References (27)

1. Morgan RL, De Young BR, McGaughy VR, et al. MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells. Cancer. 1999;87:390-394. (Pubitemid 30016611)
2. Sheibani K, Shin SS, Kezirian J, et al. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol. 1991;15:779-784.
3. Yaziji H, Battifora H, Barry TS, et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol. 2006;19:514-523.
4. Marchevsky AM, Wick MR. Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma. Appl Immunohistochem Mol Morphol. 2007;15:140-144.
5. Winter MJ, Nagtegaal ID, van Krieken JH, et al. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol. 2003;163:2139-2148. (Pubitemid 37466457)
6. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847. (Pubitemid 28331029)
7. Ellis IOSS, Schnitt SJ, Sastre-Garau X, et al. Invasive breast carcinoma. In: Tavassoli FA, Devilee P, eds. WHO Pathology and Genetics: Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003:13-23.
8. Longacre TA, Ennis M, Quenneville LA, et al. Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod Pathol. 2006;19:195-207.
9. King JE, Thatcher N, Pickering CA, et al. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology. 2006;48:223-232.
10. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
11. Latza U, Niedobitek G, Schwarting R, et al. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol. 1990;43:213-219. (Pubitemid 20087572)
12. Litvinov SV, Bakker HA, Gourevitch MM, et al. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes Commun. 1994;2:417-428. (Pubitemid 24351019)
13. Beiske K, Myklebust AT, Aamdal S, et al. Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods. Am J Pathol. 1992;141: 531-538.
14. Myklebust AT, Beiske K, Pharo A, et al. Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. Br J Cancer Suppl. 1991;14:49-53.
15. Balzar M, Bakker HA, Briaire-de-Bruijn IH, et al. Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule. Mol Cell Biol. 1998;18: 4833-4843. (Pubitemid 28343067)
16. Gosens MJ, van Kempen LC, van de Velde CJ, et al. Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Mod Pathol. 2007;20:221-232.
17. Edwards C, Oates J. OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material. J Clin Pathol. 1995;48:626-630.
18. Ruitenbeek T, Gouw AS, Poppema S. Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells. Arch Pathol Lab Med. 1994;118:265-269.
19. Lyons-Boudreaux V, Mody DR, Zhai J, et al. Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology? Arch Pathol Lab Med. 2008;132:23-28.
20. Litvinov SV, van Driel W, van Rhijn CM, et al. Expression of Ep- CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol. 1996;148:865-875.
21. Delahaye M, van der Ham F, van der Kwast TH. Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions. Diagn Cytopathol. 1997;17:115-120. (Pubitemid 27319129)
22. Sosolik RC, McGaughy VR, De Young BR. Anti-MOC-31: a potential addition to the pulmonary adenocarcinoma versus mesothelioma immunohistochemistry panel. Mod Pathol. 1997;10:716-719.
23. Nathke IS, Hinck LE, Nelson WJ. Epithelial cell adhesion and development of cell surface polarity: possible mechanisms for modulation of cadherin function, organization and distribution. J Cell Sci Suppl. 1993;17:139-145.
24. Litvinov SV, Balzar M, Winter MJ, et al. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol. 1997;139:1337-1348. (Pubitemid 27523219)
25. Droufakou S, Deshmane V, Roylance R, et al. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer. 2001;92:404-408. (Pubitemid 32249718)
26. Moll R, Mitze M, Frixen UH, et al. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol. 1993;143:1731-1742. (Pubitemid 24058276)
27. Winter MJ, Nagelkerken B, Mertens AE, et al. Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak. Exp Cell Res. 2003;285:50-58. (Pubitemid 36390155)